PBM Reporting Transparency Act

# PBM Reporting Transparency Act Summary **What the Bill Would Do** The PBM Reporting Transparency Act would require Pharmacy Benefit Managers (PBMs)—companies that manage prescription drug benefits for insurance plans—to provide more detailed public reporting on their business practices and finances. Currently, PBMs operate with limited disclosure requirements, making it difficult for regulators, insurers, and the public to understand how they set drug prices, negotiate with pharmacies, and handle rebates from drug manufacturers. **Who It Affects and Key Provisions** The bill would primarily impact PBMs, insurance companies, pharmacies, and ultimately patients and consumers who pay for prescription drugs. By requiring greater transparency, the legislation aims to shed light on practices that critics argue can increase drug costs for patients.

The specific reporting requirements would likely include details about pricing decisions, rebate structures, and fees charged to insurers and pharmacies. **Current Status** As of now, S 3729 is in committee, meaning it has been introduced but not yet voted on by the full Senate. The bill remains in the early stages of the legislative process and would need to advance through committee review and secure support from other senators before it could be considered for a floor vote.